What does UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN do?

UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN is a specialist medical practice in Brugge. Private Limited, started on 29 April 2013, 1 establishment.

What is the address of UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN?

The registered office of UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN is located at Damse Vaart-Zuid 3, 8310 Brugge.

Is UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN still active?

Yes. According to the CBE (29 September 2026) UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN is active, legal situation “Normale toestand”, started on 29 April 2013.

Is UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN registered on Peppol?

Yes, UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN is registered on the Peppol network with ID 0208:0533800007.

What is the enterprise number of UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN?

The enterprise number of UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN is BE0533800007.

When was UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN founded?

UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN was founded on 29 April 2013.

Is UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 April 2013; 5 annual accounts filed, latest fiscal year 2025; 5 directors known from the annual account.

How much profit did UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN make in 2025?

UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN posted a profit after taxes of € 4,584 in financial year 2025.

What is the revenue of UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN?

As a small company, UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 367,722.

How much does an employee at UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN earn?

The average wage cost per full-time employee at UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN was € 50,200 in 2025: staff costs of € 295,957 for 5.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN have?

According to the 2025 annual accounts, UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN has 5.9 full-time equivalents (FTE).

UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN (Private Limited)

Q: Who are the directors of UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN?

According to the 2025 annual accounts, the directors of UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN are: Dokter Kimpe Bart BV, Dr. Pieter Uvin BV, Harm Arentsen Urologie BV, Dr. Frederic Baekelandt, Dokter Christophe Ghysel BV.

Dossier UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN, printed on 29 September 2026 from databakkes.be/en/0533800007/urologisch-centrum-noord-west-vlaanderen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN from Brugge, company number BE0533800007, closed financial year 2025 with a result of € 4,584 after tax. For that financial year UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN recorded a gross margin of € 367,722 and equity of € 796,847. Compared with financial year 2024, the result moved from € 4,874 to € 4,584. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Growing

€ 796,847

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 4,584

▼ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 560,466

▲ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 43,097.

People and assets in 2025

Full-time equivalents

5.9

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 295,957

▲ 4% vs 2024

€ 50,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,392

▼ 85% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 38,266

▲ 6% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 368,151 Gross margin 2022: € 368,151 First fiscal year in the series	€ 396,214 Gross margin 2023: € 396,214 ▲ 8% vs 2022 (€ 368,151) Favourable step	€ 353,780 Gross margin 2024: € 353,780 ▼ 11% vs 2023 (€ 396,214) Unfavourable step	€ 367,722 Gross margin 2025: € 367,722 ▲ 4% vs 2024 (€ 353,780) Favourable step	▲ 4%
Profit after taxes	€ 3,852 Profit after taxes 2022: € 3,852 First fiscal year in the series	€ 4,615 Profit after taxes 2023: € 4,615 ▲ 20% vs 2022 (€ 3,852) Favourable step	€ 4,874 Profit after taxes 2024: € 4,874 ▲ 6% vs 2023 (€ 4,615) Favourable step	€ 4,584 Profit after taxes 2025: € 4,584 ▼ 6% vs 2024 (€ 4,874) Unfavourable step	▼ 6%
Equity	€ 788,155 Equity 2022: € 788,155 First fiscal year in the series	€ 787,389 Equity 2023: € 787,389 Unchanged (€ 788,155) Unfavourable step	€ 792,263 Equity 2024: € 792,263 ▲ 1% vs 2023 (€ 787,389) Favourable step	€ 796,847 Equity 2025: € 796,847 ▲ 1% vs 2024 (€ 792,263) Favourable step	▲ 1%
Total debts	€ 873,853 Total debts 2022: € 873,853 First fiscal year in the series	€ 982,490 Total debts 2023: € 982,490 ▲ 12% vs 2022 (€ 873,853) Unfavourable step	€ 1,190,280 Total debts 2024: € 1,190,280 ▲ 21% vs 2023 (€ 982,490) Unfavourable step	€ 1,180,351 Total debts 2025: € 1,180,351 ▼ 1% vs 2024 (€ 1,190,280) Favourable step	▼ 1%
Cash	€ 345,972 Cash 2022: € 345,972 First fiscal year in the series	€ 365,958 Cash 2023: € 365,958 ▲ 6% vs 2022 (€ 345,972) Favourable step	€ 467,000 Cash 2024: € 467,000 ▲ 28% vs 2023 (€ 365,958) Favourable step	€ 560,466 Cash 2025: € 560,466 ▲ 20% vs 2024 (€ 467,000) Favourable step	▲ 20%
Land & buildings	€ 268,823 Land & buildings 2022: € 268,823 First fiscal year in the series	€ 242,874 Land & buildings 2023: € 242,874 ▼ 10% vs 2022 (€ 268,823) Unchanged	€ 216,926 Land & buildings 2024: € 216,926 ▼ 11% vs 2023 (€ 242,874) Unchanged	€ 190,977 Land & buildings 2025: € 190,977 ▼ 12% vs 2024 (€ 216,926) Unchanged	▼ 12%
Retained profit	€ 36,280 Retained profit 2022: € 36,280 First fiscal year in the series	€ 33,639 Retained profit 2023: € 33,639 ▼ 7% vs 2022 (€ 36,280) Unfavourable step	€ 38,513 Retained profit 2024: € 38,513 ▲ 14% vs 2023 (€ 33,639) Favourable step	€ 43,097 Retained profit 2025: € 43,097 ▲ 12% vs 2024 (€ 38,513) Favourable step	▲ 12%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 7,256 Dividend 2023: € 7,256 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 7,256) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,662,009 Balance sheet total 2022: € 1,662,009 First fiscal year in the series	€ 1,769,879 Balance sheet total 2023: € 1,769,879 ▲ 6% vs 2022 (€ 1,662,009) Unchanged	€ 1,982,543 Balance sheet total 2024: € 1,982,543 ▲ 12% vs 2023 (€ 1,769,879) Unchanged	€ 1,977,197 Balance sheet total 2025: € 1,977,197 Unchanged (€ 1,982,543) Unchanged
Employees (FTE)	5.4 Employees (FTE) 2022: 5.4 First fiscal year in the series	5.9 Employees (FTE) 2023: 5.9 ▲ 0.5 vs 2022 (5.4) Unchanged	5.9 Employees (FTE) 2024: 5.9 Unchanged (5.9) Unchanged	5.9 Employees (FTE) 2025: 5.9 Unchanged (5.9) Unchanged

Key figures of UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN?

What happened at UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 4,584 (▼ 6% vs 2024). Source: NBB ↗
2023 Dr. Pieter Uvin BV became a director. NBB
2022 Dr. Frederic Baekelandt became a director. NBB
2021 Harm Arentsen Urologie BV became a director. NBB
Apr 30, 2013 New establishment in Brugge. KBO
Apr 29, 2013 Start of the company according to the CBE. KBO
2013 Dokter Kimpe Bart BV became a director. NBB
2013 Dokter Christophe Ghysel BV became a director. NBB

In short

From € 3,852 profit in 2022 to € 4,584 profit in 2025.

Paid € 14,930 in corporate taxes since 2022.

Best year ever: 2024, with € 4,874 profit.

On average € 62,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN? We notify you, reason included.

Follow UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

DR. KIMPE BART 20%

Harm Arentsen Urologie 16.7%

The stake of DR. KIMPE BART, Harm Arentsen Urologie comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN

Behind UROLOGISCH CENTRUM NOORD WEST-VLAANDEREN are Dokter Kimpe Bart BV, Dr. Pieter Uvin BV, Harm Arentsen Urologie BV, Dr. Frederic Baekelandt and Dokter Christophe Ghysel BV. The shares are held by DR. KIMPE BART (20%) and Harm Arentsen Urologie (16.7%).

See the full network in the app